Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

R. T. Eagan, S. Frytak, E. T. Creagan, J. N. Ingle, L. K. Kvols, D. T. Coles

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

The evaluation of cyclophosphamide, Adriamycin, and cis-platinum given by 6-hour infusion with mannitol (CAP-II) is the subject of this report. Forty-two patients, 22 with adenocarcinoma (ACA) and 20 with large cell carcinoma (LCC) of the lung, were entered in the study.

Original languageEnglish (US)
Pages (from-to)1589-1591
Number of pages3
JournalCancer Treatment Reports
Volume63
Issue number9-10
StatePublished - Dec 1 1979

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung'. Together they form a unique fingerprint.

  • Cite this